Role of macrophage tissue infiltration in metabolic diseases

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 8, Issue 4, 2005, Pages 347-354

  Bouloumié, Anne ^a,b   Curat, Cyrile Anne ^a   Sengenès, Coralie ^a   Lolmède, Karine ^b   Miranville, Alexandra ^a   Busse, Rudi ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CHU RANGUEIL   (France)

Author keywords

Adipocyte; Cytokine; Endothelial cell; Inflammation; Obesity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHEMOKINE; COLONY STIMULATING FACTOR 1; HAPTOGLOBIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; LYSOPHOSPHATIDIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN RELATED PROTEIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; RESISTIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL TISSUE; ATHEROSCLEROSIS; DIABETES MELLITUS; ENERGY METABOLISM; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; TISSUE GROWTH; WHITE ADIPOSE TISSUE;

EID: 20844460279     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mco.0000172571.41149.52     Document Type: Review

References (90)

1. Juge-Aubry CE, Somm E, Giusti V, et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003; 52:1104-1110.
2. Bruun JM, Linn AS, Madan AK, et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 2004; 286;E8-E13.
3. Straczkowski M, Dzienis-Straczkowska S, Stepien A, et al. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002; 87; 4602-4606.
4. Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145:2273-2282.
5. Juge-Aubry CE, Somm E, Chicheportiche R, et al. Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 2004; 89:2652-2658.
6. Meier CA, Bobbioni E, Gabay C, et al. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 2002; 87:1184-1188.
7. Esposito K, Pontillo A, Ciotola M, et al. Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 2002; 87:3864-3866.
8. Lihn AS, Bruun JM, He G, et al. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219:9-15.
9. Fain JN, Cheema PS, Bahouth SW, Lloyd HM. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003; 300:674-678.
10. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107:671-674.
11. Peeraully MR, Jenkins JR, Trayhurn P. NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. Am J Physiol Endocrinol Metab 2004; 287:E331-E339.
12. Sjoholm K, Palming J, Olofsson LE, et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 2005; 90:2233-2239.
13. Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109:726-732.
14. Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005; 48:519-528.
15. Fain JN, Bahouth SW, Madan AK. Haptoglobin release by human adipose tissue in primary culture. J Lipid Res 2004; 45:536-542.
16. Chiellini C, Santini F, Marsili A, et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab 2004; 89:2678-2683.
17. Leinonen E, Hurt-Camejo E, Wiklund O, et al. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003; 166:387-394.
18. Pannacciulli N, Giorgino F, Martina RA, et al. Effect of family history of type 2 diabetes on white blood cell count in adult women. Obes Res 2003; 11:1232-1237.
19. Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110:1564-1571. This study provides evidence that the nuclear factor kappa B pathway is activated in mononuclear cells from obese individuals and suggests an inflammatory modulatory effect of free fatty acids.
20. van Dielen FM, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004; 89:4062-4068. This article presents a long-term study performed in morbidly obese patients after weight loss as a result of gastric restrictive surgery and provides evidence that inflammatory mediators remain elevated for at least 3 months postoperatively and reach near-normal values 2 year after surgery.
21. Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14:589-600.
22. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289:1799-1804.
23. Ryan AS, Nicklas BJ. Reductions in plasma cytokine levels with weight loss 9 improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 2004; 27:1699-1705. This study reports a reduction in inflammatory markers associated with improvements in insulin sensitivity in overweight/obese postmenopausal women who completed 6 months of weight loss induced by diet and exercise.
24. Diamant M, Lamb HJ, van de Ree MA, et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 2005; 90:1495-1501. This study demontrates that carotid stiffness is associated with visceral obesity in patients with uncomplicated type 2 diabetes, and suggests that this association is mediated by circulating IL-6 and C-reactive protein.
25. Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003; 11:525-531.
26. Maachi M, Pieroni L, Bruckert E, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28:993-997. This study demonstrates that the relationship observed in non-diabetic obese women between adipose tissue levels of IL-6, TNF-α and ieptin and serum C-reactive protein level is dependent on the fat amount.
27. Soukas A, Cohen P, Socci ND, Friedman JM. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 2000; 14:963-980.
28. Moraes RC, Blondet A, Birkenkamp-Demtroeder K, et al. Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology 2003; 144:4773-4782.
29. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112:1821-1830.
30. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808.
31. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18:1657-1669. This study reports that weight loss improves the inflammatory profile of obese individuals during very low calorie diet through a decrease in proinflammatory factors and an increase in anti-inflammatory molecules in adipose tissue. The genes are expressed mostly in the stromavascular fraction of adipose tissue, which is shown to contain numerous macrophages.
32. Arvidsson E, Viguerie N, Andersson I, et al. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004; 53:1966-1971. This study demonstrates that moderate caloric restriction but not macronutrient composition influences the production and secretion of adipose tissue-derived proteins during weight reduction in the subcutaneous adipose tissue in obese women.
33. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92:347-355. A complete and comprehensive review on the role of adipokines.
34. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15:2792-2800. A complete review on the link between adipose tissue and inflammation.
35. Curat CA, Miranville A, Sengenes C, et al. From blood monocytes to adipose oo tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53:1285-1292. This study demonstrates that the SVF of human adipose tissue contains macrophages, the percentage of which increases with the BMI. It describes an approach to isolate such a population specifically by the use of magnetic microbeads coupled to antibody. Moreover, it demonstrates that human adipocyte productions directly activate human adipose tissue-derived endothelial cells and promote the enhanced adhesion and transmigration of human blood monocytes.
36. Hume DA, Ross IL, Himes SR, et al. The mononuclear phagocyte system revisited. J Leukoc Biol 2002; 72:621-627.
37. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19:71-82.
38. Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 2003; 278:9850-9855.
39. Saillan-Barreau C, Cousin B, Andre M, et al. Human adipose cells as candidates in defense and tissue remodeling phenomena. Biochem Biophys Res Commun 2003; 309:502-505.
40. Weber C. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecuies. J Mol Med 2003; 81:4-19.
41. Takahashi K, Mizuarai S, Araki H, et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 2003; 278:46654-46660.
42. Bruun JM, Lihn AS, Pedersen SB, Richelsen B. MCP-1 release is higher in visceral than subcutaneous human adipose tissue. Implication of macrophages resident in the adipose tissue. J Clin Endocrinol Metab 2005; 90:2282-2289.
43. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003; 100:7265-7270.
44. Gerhardt CC, Romero IA, Cancello R, et al. Chemokines control fat accumulation and ieptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175:81-92.
45. Levine JA, Jensen MD, Eberhardt NL, O'Brien T. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest 1998; 101:1557-1564.
46. Kim CS, Kawada T, Yoo H, et al. Macrophage inflammatory protein-related protein-2, a novel CC chemokine, can regulate preadipocyte migration and adipocyte differentiation. FEBS Lett 2003; 548:125-130.
47. Skurk T, Herder C, Kraft I, et al. Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 2005; 146:1006-1011.
48. Dandona P, Aljada A, Ghanim H, et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004; 89:5043-5047.
49. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, et al. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003; 46:1483-1488.
50. Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 2003; 1:1575-1579.
51. He G, Pedersen SB, Bruun JM, et al. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects. Horm Metab Res 2003; 35:178-182.
52. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 2005; 29:146-150.
53. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999; 13:1231-1238.
54. Tchoukalova YD, Sarr MG, Jensen MD. Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul lntegr Comp Physiol 2004; 287:R1132-R1 140. This study describes the heterogeneity of the different fat locations in terms of preadipocyte and macrophage populations.
55. Robker RL, Collins RG, Beaudet AL, et al. Leukocyte migration in adipose tissue of mice null for ICAM-1 and Mac-1 adhesion receptors. Obes Res 2004; 12:936-940.
56. Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104:2224-2234. A complete review on the influence of hypoxia on macrophage recruitment.
57. Lolmede K, Durand SFV, Galitzky J, et al. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 2003; 27:1187-1195.
58. Llodra J, Angeli V, Liu J, et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A 2004; 101:11779-11784. The present study involves a defect in the process of blood monocyte emigration in atherosclerosis.
59. Ferry G, Tellier E, Try A, et al. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Upregulated expression with adipocyte differentiation and obesity. J Biol Chem 2003; 278:18162-18169.
60. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76:509-513. This review provides evidence about the ability of macrophages to adapt to a changing environment.
61. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23-35.
62. Duffield JS. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 2003; 104:27-38.
63. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-1761. This study demonstrates an increased systemic but also adipose tissue oxidative stress in obesity.
64. Gainsford T, Willson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A 1996; 93:14564-14568.
65. Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 2004; 314:151-158.
66. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96:1723-1732.
67. Wolf AM, Wolf D, Rumpold H, et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1 RA in human leukocytes. Biochem Biophys Res Commun 2004; 323:630-635.
68. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109:2046-2049.
69. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12:57-65.
70. Kumar S, Bahn RS. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 2003; 88:4246-4250.
71. Rupnick MA, Panigrahy D, Zhang CY, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 2002; 99:10730-10735.
72. Fukumura D, Ushiyama A, Duda DG, et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 2003; 93:e88-e97.
73. Brakenhielm E, Cao R, Gao B, et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 2004; 94:1579-1588. This study shows that the delivery of an angiogenesis inhibitor in mice prevents diet-induced obesity by a reduction of vascularity in the adipose tissue.
74. Neels JG, Thinnes T, Loskutoff DJ. Angiogenesis in an in vivo model of adipose tissue development. FASEB J 2004; 18:983-985. This study describes the formation of new blood vessels after the subcutaneous implantation of murine preadipocytes in mice.
75. Miranville A, Heeschen C, Sengenes C, et al. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004; 110:349-355. This study provides the first evidence of an increased capillary network with the development of the human fat mass by fluorescence-activated cell sorter analysis.
76. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004; 113:1040-1050. This study demonstrates the role of macrophages in lymphangiogenesis and haemangiogenesis in a model of inflammatory neovascularization in the cornea.
77. Khmelewski E, Becker A, Meinertz T, Ito WD. Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res 2004; 95:E56-E64.
78. Linscheid P, Seboek D, Schaer DJ, et al. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004; 32:1715-1721.
79. Lehrke M, Reilly MP, Millington SC, et al. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med 2004; 1:e45. This study demonstrates that the inflammatory condition induces resistin expression in primary human macrophages and increases plasma resistin concentrations.
80. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-2556. A complete review on the roles of adipose tissue.
81. Verlohren S, Dubrovska G, Tsang SY, et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44:271-276. This study provides evidence that perivascular adipose tissue exerts a control on vasodilation.
82. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 2004; 286:H1107-H1113.
83. Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J. Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann NY Acad Sci 2001; 947:68-90.
84. Okamoto E, Couse T, De Leon H, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 2001; 104:2228-2235.
85. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108:2460-2466.
86. Castrillo A, Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 2004; 20:455-480. A complete review on the family of peroxisome proliferator-activated receptors.
87. Cock TA, Houten SM, Auwerx J. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep 2004; 5:142-147. A complete review on the roles of peroxisome proliferator-activated receptor gamma.
88. Makowski L, Hotamisligil GS. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004; 134: 2464S-2468S. A complete review on the fatty acid binding proteins and their role in inflammation and metabolism.
89. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001; 7:699-705.
90. Layne MD, Patel A, Chen YH, et al. Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J 2001; 15:2733-2735.